Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Sep;47(3):212-22.
doi: 10.3947/ic.2015.47.3.212. Epub 2015 Sep 30.

Antiviral Treatment Guidelines for Middle East Respiratory Syndrome

Yong Pil Chong  1 , Joon Young Song  2 , Yu Bin Seo  3 , Jae-Phil Choi  4 , Hyoung-Shik Shin  5 ; Rapid Response Team
Affiliations
Review

Antiviral Treatment Guidelines for Middle East Respiratory Syndrome

Yong Pil Chong et al. Infect Chemother. 2015 Sep.

Abstract

Middle East respiratory syndrome (MERS) is an acute infectious disease of the respiratory system caused by the new betacoronavirus (MERS coronavirus, MERS-CoV), which shows high mortality rates. The typical symptoms of MERS are fever, cough, and shortness of breath, and it is often accompanied by pneumonia. The MERS-CoV was introduced to Republic of Korea in May 2015 by a patient returning from Saudi Arabia. The disease spread mostly through hospital infections, and by the time the epidemic ended in August, the total number of confirmed diagnoses was 186, among which 36 patients died. Reflecting the latest evidence for antiviral drugs in the treatment of MERS-CoV infection and the experiences of treating MERS patients in Republic of Korea, these guidelines focus on antiviral drugs to achieve effective treatment of MERS-CoV infections.

Keywords: Antiviral; Coronavirus; MERS; Treatment.

PubMed Disclaimer

References

    1. Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet. 2015 [Epub ahead of Print] - PMC - PubMed
    1. Korean Centers for Disease Control & Prevention. MERS Statistics. [Assessed 16 August, 2015]. Available at: http://www.mers.go.kr/mers/html/jsp/Menu_C/list_C4.jsp.
    1. WHO. Middle East respiratory syndrome coronavirus (MERS-CoV) [Accessed 16 August, 2015]. Available at: http://www.who.int/emergencies/mers-cov/en/
    1. Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3:e343. - PMC - PubMed
    1. Omrani AS, Saad MM, Baig K, Bahloul A, Abdul-Matin M, Alaidaroos AY, Almakhlafi GA, Albarrak MM, Memish ZA, Albarrak AM. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis. 2014;14:1090–1095. - PMC - PubMed